Sources of Lab rec.
Suppliers of Lab polyclonals
VWR alternatives of Lab Assays
Compare rec. lab reagents for research
Suppliers for Lab polyclonals
HIV-1, HIV-2 Protease Substrate Peptide |
||
abx265644-200tests | Abbexa | 200 tests |
HIV-1, HIV-2 Protease Substrate Peptide |
||
abx265644-50tests | Abbexa | 50 tests |
HIV Reverse Transcriptase (HIV-RT) Recombinant |
||
GWB-56D50E | GenWay Biotech | 0.025 mg |
HIV Rev |
||
GWB-96E989 | GenWay Biotech | 0.05 ml |
HIV QK10 |
||
5-01336 | CHI Scientific | 4 x 5mg |
HIV QK10 |
||
MBS8246609-10mg | MyBiosource | 10mg |
HIV QK10 |
||
MBS8246609-1mg | MyBiosource | 1mg |
Polyclonal ETO polyclonal antibody |
|||
APR00372G | Leading Biology | 0.05ml | 580.8 EUR |
Polyclonal SHH Polyclonal Antibody |
|||
APR00434G | Leading Biology | 0.1mg | 580.8 EUR |
Polyclonal ETO polyclonal antibody |
|||
APR00435G | Leading Biology | 0.1ml | 633.6 EUR |
Polyclonal p53 polyclonal antibody |
|||
APR00443G | Leading Biology | 0.05mg | 633.6 EUR |
Polyclonal G9a polyclonal antibody |
|||
APR00448G | Leading Biology | 0.1ml | 580.8 EUR |
Polyclonal PML polyclonal antibody |
|||
AMR09397G | Leading Biology | 0.05mg | 580.8 EUR |
Polyclonal YY1 polyclonal antibody |
|||
APR14018G | Leading Biology | 0.1ml | 580.8 EUR |
Polyclonal RARA polyclonal antibody |
|||
APR00370G | Leading Biology | 0.05ml | 580.8 EUR |
Our used polyclonals in Pubmed.
Polyclonal G9a polyclonal antibody |
|||
APR00448G | Leading Biology | 0.1ml | 580.8 EUR |
Polyclonal PML polyclonal antibody |
|||
AMR09397G | Leading Biology | 0.05mg | 580.8 EUR |
Polyclonal YY1 polyclonal antibody |
|||
APR14018G | Leading Biology | 0.1ml | 580.8 EUR |
Polyclonal RARA polyclonal antibody |
|||
APR00370G | Leading Biology | 0.05ml | 580.8 EUR |
Polyclonal EzH2 polyclonal antibody |
|||
APR00373G | Leading Biology | 0.05mg | 580.8 EUR |
Compare rec. lab reagents for research
Suppliers for Lab Assays
CASP14 (Caspase-14, CASP-14, Caspase-14 Subunit p19, Caspase-14 Subunit p10) |
||
MBS6013237-01mg | MyBiosource | 0.1(mg |
CASP14 (Caspase-14, CASP-14, Caspase-14 Subunit p19, Caspase-14 Subunit p10) |
||
MBS6013237-5x01mg | MyBiosource | 5x0.1mg |
Rat Caspase-2(Caspase-2) ELISA Kit |
||
ER1468 | FN Test | 96T |
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Rattus;Sensitivity: 0.094 ng/ml |
||
Rat Caspase-9(Caspase-9)ELISA Kit |
||
NSL1644r | Sunlong | 96 Tests |
Rat Caspase-8(Caspase-8)ELISA Kit |
||
NSL1645r | Sunlong | 96 Tests |
Rat Caspase-3(Caspase-3)ELISA Kit |
||
NSL1646r | Sunlong | 96 Tests |
Rat Caspase-2 (Caspase-2) ELISA Kit |
||
MBS7606174-10x96StripWells | MyBiosource | 10x96-Strip-Wells |
Recombinant Humanp21 Recombinant Protein |
|||
92-035 | ProSci | 0.05 mg | 821.4 EUR |
TWEAK, recombinant / TNFSF12, recombinant (Human) |
|||
054-85 | PHOENIX PEPTIDE | 10 μg | 261.36 EUR |
TAGLN Recombinant Protein (Rat) (Recombinant- Tag) |
|||
RP232205 | ABM | 100 ug | Ask for price |
TAGLN2 Recombinant Protein (Rat) (Recombinant Tag) |
|||
RP232208 | ABM | 100 ug | Ask for price |
TAGLN3 Recombinant Protein (Rat) (Recombinant Tag) |
|||
RP232211 | ABM | 100 ug | Ask for price |
TAGLN3 Recombinant Protein (Rat) (Recombinant Tag) |
|||
RP232214 | ABM | 100 ug | Ask for price |
TAGAP Recombinant Protein (Human) (Recombinant- Tag) |
|||
RP030880 | ABM | 100 ug | Ask for price |
TAGLN Recombinant Protein (Human) (Recombinant- Tag) |
|||
RP030883 | ABM | 100 ug | Ask for price |
Our used References in Pubmed.
rec IL-3 (human) |
|||
H-7730.0002 | Bachem | 2.0µg | 194.4 EUR |
rec IL-3 (human) |
|||
H-7730.0010 | Bachem | 10.0µg | 457.2 EUR |
rec IL-6 (human) |
|||
H-7735.0005 | Bachem | 5.0µg | 194.4 EUR |
rec IL-6 (human) |
|||
H-7735.0020 | Bachem | 20.0µg | 457.2 EUR |
rec IL-4 (human) |
|||
H-9630.0002 | Bachem | 2.0µg | 313.2 EUR |
https://tumori.net/
Difference between isolated and hydrolyzed proteins
In recent years, the use of food supplements has undergone a real surge. Accomplices are the hectic and increasingly selective lifestyles, which do not allow you to take on all the elements necessary for a complete diet, but also an increasingly high quality of products, which attracts more and more athletes, the elderly and future mothers. For many companies, this was the beginning of a business that continues today and marks positive points: the nutraceutical market.
A large clientele is looking for food supplements containing proteins, which can be found in isolated or hydrolyzed form. To direct the customer towards one type of product, rather than another, correct information is important, i.e. explaining the content of the product and the advantages of one over the other.
What is the difference between isolated and hydrolyzed proteins?
We state that focusing on isolated or hydrolyzed proteins depends on the company’s objective and the technologies available.
The isolated proteins are produced by purification techniques and, once isolated, they do not undergo further modifications. The absorption time by the body changes depending on the source of origin of the protein, it can vary between 40 minutes and an hour.
Hydrolysed proteins, on the other hand, undergo a further hydrolysis process, usually by enzymes, which allows the macromolecules to be broken down into shorter peptides. If on the one hand the cost of the product increases, on the other the great advantage is that the assimilation times of the product are reduced and the product. Hydrolysed proteins, in fact, can be assimilated in just over ten minutes. In addition, there is several experimental evidence showing that hydrolysates facilitate post-workout recovery and maximize muscle anabolism.
There are several companies that have decided to send both types into production, thus covering a large portion of the market.
It is important to rely on an innovative laboratory!
Since it is a very competitive and fast growing market, given the constant demand from consumers, it is necessary to entrust the development and research of these products to a laboratory that is actually innovative and competent, such as Bict, which offers solutions and standardized chemical and biotechnological processes applicable directly to the type of production desired (supplements, isolated proteins, hydrolysates, for example) thanks to an expert and creative team and an automated system that reduces both development time and human error.